share_log

A Quick Look at Today's Ratings for Marsh & McLennan(MMC.US), With a Forecast Between $201 to $244

Moomoo News ·  Jul 19 09:00  · Ratings

On Jul 19, major Wall Street analysts update their ratings for $Marsh & McLennan (MMC.US)$, with price targets ranging from $201 to $244.

BofA Securities analyst Grace Carter maintains with a hold rating, and adjusts the target price from $233 to $244.

Evercore analyst David Motemaden maintains with a buy rating, and adjusts the target price from $221 to $235.

Roth MKM analyst Harry Fong maintains with a hold rating, and adjusts the target price from $175 to $220.

KBW analyst Meyer Shields maintains with a sell rating, and adjusts the target price from $195 to $201.

Here are the latest investment ratings and price targets for $Marsh & McLennan (MMC.US)$ from 4 analysts:

StockTodayLatestRating_mm_205119_20240719_en

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment